Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population

FOS-like antigen-2 (FOSL-2), a member of the FOS gene family, encode leucine zipper proteins that can heterodimerize with proteins of Jun family. Thus, activating protein (AP)-1 transcription factor is formed, has a crucial role in proliferation, differentiation and apoptosis of normal tissue as wel...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental otorhinolaryngology Vol. 7; no. 1; pp. 42 - 46
Main Authors Kim, Seung Woo, Kim, Choon Dong, Chung, Joo Ho, Kwon, Kee Hwan
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Otorhinolaryngology-Head and Neck Surgery 01.03.2014
대한이비인후과학회
Subjects
Online AccessGet full text
ISSN1976-8710
2005-0720
DOI10.3342/ceo.2014.7.1.42

Cover

More Information
Summary:FOS-like antigen-2 (FOSL-2), a member of the FOS gene family, encode leucine zipper proteins that can heterodimerize with proteins of Jun family. Thus, activating protein (AP)-1 transcription factor is formed, has a crucial role in proliferation, differentiation and apoptosis of normal tissue as well as oncogenic transformation and progression. We performed an association study of single nucleotide polymorphisms (SNPs) in the FOSL-2 with papillary thyroid cancer (PTC). We also estimated the relationships between the SNPs and the clinicopathologic characteristics of PTC. One promoter SNPs (rs925255) of FOSL-2 gene were genotyped with direct sequencing method in 94 PTC and 213 controls. PTC patients were dichotomized and compared with respect to clinical parameters of PTC. Genetic data were analyzed using Helixtree, SNPAnalyzer, SNPStats. Multivariate logistic regression analysis was fulfilled to evaluate the genetic effect with adjustment for age and sex. SNP (rs925255) in FOSL-2 showed a significant association (codominant 1 model [G/G vs. A/G]: odds ratio [OR], 0.531, 95% confidence interval [CI], 0.293 to 0.96, P=0.036; dominant model: OR, 0.50, 95% CI, 0.28 to 0.89, P=0.015) with PTC. The frequency of allele G in rs925255 was also significantly associated with PTC (OR, 0.59; 95% CI, 0.34 to 0.91; P=0.02). But we fail to prove significant association between this polymorphism (rs925255) and clinico-pathological parameters. Our findings suggest that the rs925255 SNP and its allele G show significant association with the PTC in Korean population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-SER000001014.2014.7.1.001
http://dx.doi.org/10.3342/ceo.2014.7.1.42
ISSN:1976-8710
2005-0720
DOI:10.3342/ceo.2014.7.1.42